The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)
Introduction: Multicriteria Decision Analysis (MCDA) provides a framework that enhances transparency and repeatability of decisions taken on a multicriteria basis. Objective: This analysis aims at assessing obinutuzumab compared to rituximab used as a first-line treatment for Follicular Lymphoma...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AboutScience Srl
2019-11-01
|
| Col·lecció: | AboutOpen |
| Matèries: | |
| Accés en línia: | https://journals.aboutscience.eu/index.php/aboutopen/article/view/302 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|